World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
77
Citations
26136
World Ranking
1332
National Ranking
587

Scott Koenig publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Scott Koenig sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 184 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Scott Koenig D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Scott Koenig sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 77 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Scott Koenig is a researcher affiliated with MacroGenics in the United States. Their work primarily spans the fields of medicine and immunology and microbiology, with a notable focus on oncology and immunology as subfields. The scientist's research addresses topics such as cancer immunotherapy and biomarkers, immunotherapy and immune responses, CAR-T cell therapy research, HER2/EGFR in cancer research, monoclonal and polyclonal antibodies research, HIV research and treatment, and chronic lymphocytic leukemia research.

Koenig has contributed to several recent publications, including:

  • Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer (2021, JAMA Oncology)
  • Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer (2020, Molecular Cancer Therapeutics)
  • Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors (2022, Molecular Cancer Therapeutics)
  • prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis (2023, Proceedings of the National Academy of Sciences)
  • Abstract 5203: MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3, exhibits immunomodulatory activity and enhanced antitumor activity in combination with checkpoint inhibitors (2020, Cancer Research)

The primary publication venues where Koenig's work appears include:

  • Cancer Research
  • Molecular Cancer Therapeutics
  • UNC Libraries
  • JAMA Oncology
  • Proceedings of the National Academy of Sciences

Frequent collaborators in Koenig's research efforts include Ezio Bonvini, Paul A. Moore, Juniper A. Scribner, Thomas Son, and Michael Chiechi. These coauthors have consistently contributed to various projects in conjunction with Koenig.

Best Publications

  • Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

    Akio Adachi;Howard E. Gendelman;Scott Koenig;Thomas Folks

  • Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

    Scott Koenig;Howard E. Gendelman;Jan M. Orenstein;Mauro Carlo Dal Canto

  • A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.

    Dennis R. Burton;Carlos F. Barbas;Mats A. A. Persson;Scott Koenig

  • Circulating CD8 + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

    Steven Jacobson;Hisatoshi Shida;Dale E. McFarlin;Anthony S. Fauci

  • Development of a Humanized Monoclonal Antibody (MEDI-493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

    Syd Johnson;Cynthia Oliver;Gregory A. Prince;Val G. Hemming

  • Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.

    Solomon Langermann;Solomon Langermann;Susan Palaszynski;Susan Palaszynski;Michelle Barnhart;Michelle Barnhart;Gale Auguste;Gale Auguste

  • Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial.

    Nicole Sherry;William Hagopian;Johnny Ludvigsson;Sunil M Jain

  • Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection

    Theresa M. Wizemann;Jon H. Heinrichs;John E. Adamou;Alice L. Erwin

  • Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcγ receptors

    Jeffrey B. Stavenhagen;Sergey Gorlatov;Nadine Tuaillon;Christopher T. Rankin

  • Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression.

    Scott Koenig;Anthony J. Conley;Yambasu A. Brewah;Gary M. Jones

  • Biological and biochemical characterization of a cloned leu-3− cell surviving infection with the acquired immune deficiency syndrome retrovirus

    T. M. Folks;D. Powell;M. Lightfoote;S. Koenig

  • Application of dual affinity retargeting molecules to achieve optimal redirected T-cell killing of B-cell lymphoma

    Paul A. Moore;Wenjun Zhang;G. Jonah Rainey;Steve Burke

  • Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.

    Solomon Langermann;Roland Möllby;Jeanne E. Burlein;Susan R. Palaszynski

  • FcGammaRIIB Specific Antibodies and Methods of Use Thereof

    Scott Koenig;Maria Concetta Veri

  • Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infection

    Anthony S. Fauci;Steven M. Schnittman;Guido Poli;Scott Koenig

  • Selective dysregulation of the FcγIIB receptor on memory B cells in SLE

    Meggan Mackay;Anfisa Stanevsky;Tao Wang;Cynthia Aranow

  • Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

    Deryk Loo;Ralph F. Alderson;Francine Z. Chen;Ling Huang

  • Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells

    Kavita M. Dhodapkar;Jacob L. Kaufman;Marc Ehlers;Devi K. Banerjee

  • Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

    C K Stover;G P Bansal;M S Hanson;J E Burlein

  • Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses

    P L Earl;S Koenig;B Moss

Frequent Co-Authors

Ezio Bonvini
Ezio Bonvini Center for Biologics Evaluation and Research
Syd Johnson
Syd Johnson AstraZeneca (United Kingdom)
Herren Wu
Herren Wu AstraZeneca (United Kingdom)
Paul A. Moore
Paul A. Moore MacroGenics (United States)
Ronald L. Wilder
Ronald L. Wilder National Institutes of Health
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Howard E. Gendelman
Howard E. Gendelman University of Nebraska Medical Center
Elaine I. Tuomanen
Elaine I. Tuomanen St. Jude Children's Research Hospital
Douglas H. Smith
Douglas H. Smith University of Pennsylvania
Giuseppe Pantaleo
Giuseppe Pantaleo University of Lausanne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to diverse career opportunities, but it’s important to consider various educational paths to find the best fit for your goals. For those facing unique challenges, such as individuals wondering what can a felon go to college for, there are accessible online degrees that can lead to rewarding careers in health sciences and beyond.

Specialized roles like becoming a functional nurse practitioner are growing in demand. This path combines healthcare knowledge with patient-centered approaches, often requiring additional certifications but offering a meaningful role in patient care and medical research.

Alternatively, careers in healthcare administration, such as the professional coder certification, provide stable job prospects. These roles focus on medical coding and billing, critical for the smooth operation of health systems and directly impacting healthcare data accuracy.

Another growing field linked to microbiology knowledge is health information management. Exploring health information management jobs salary can help you understand the financial benefits and responsibilities of managing patient data, compliance, and healthcare technologies.

Best Scientists Citing Scott Koenig

Trending Scientists

Recently Published Articles